NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 11 04:00PM ET
25.81
Dollar change
-0.40
Percentage change
-1.53
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-6.25% Total Holdings50 Perf Week1.69%
SponsorTema ETF Type Tagsequity Return% 3Y- AUM67.02M Perf Month-0.65%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter16.63%
Index- Average Maturity Tags- Return% 10Y 52W High29.85 -13.55% Perf Half Y2.60%
Index Weighting Commodity Type Tags- Return% SI 52W Low20.10 28.44% Perf YTD6.18%
Active/Passive Quant Type Tags- Flows% 1M-8.48% Volatility2.33% 2.41% Perf Year-5.45%
Dividend TTM0.50 (1.93%) ESG Type Tags- Flows% 3M-3.39% ATR (14)0.66 Perf 3Y-
Dividend Ex-DateDec 11, 2024 Dividend Type Sector/Theme Flows% YTD32.37% RSI (14)57.65 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.98 Perf 10Y-
Expense0.75% Growth/Value SMA202.38% Flows% 3Y Rel Volume0.30 Prev Close26.21
Inverse/Leveraged Market Cap SMA504.84% Flows% 5Y Avg Volume17.95K Price25.81
IPOAug 16, 2023 Option/ShortNo / Yes SMA2001.30% Trades Volume5,405 Change-1.53%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.